Featured Story | By Max Bayer Novavax touted early data of its combo vaccine for the flu and COVID-19, saying the shot elicited an immune response comparable to standalone flu and COVID shots. The results come as the company is still awaiting a decision from the FDA on its EUA submission for its COVID jab. read more |
| |
|---|
|
Top Stories By Max Bayer Aptinyx is putting the stop sign up on the higher dose arm of a phase 2b trial testing the company's PTSD med in order to conserve cash. The 150-mg arm was slated to start up after the 50-mg was initiated, which happened in December. read more By Gabrielle Masson Data-driven therapeutics company Octant Bio is entering unexplored frontiers with $80 million in-pocket and the belief that synthetic biology advances are paving the way for a new kind of biotech. read more Sponsored by: Precision for Medicine Biomarker discovery and development are critical for advancing oncology therapeutics and informing patient management. Experts discuss evaluating biomarkers in drug-diagnostic co-development programs. read more By Nick Paul Taylor Four years ago, the FDA crushed Ampio’s stock by ruling one of its pivotal osteoarthritis studies fell short of the required standard. Ampio duly ran another study—only for the FDA to deem the COVID-19-ravaged trial to be unacceptable, sinking the stock once again and leading the biotech to consider embarking on yet another phase 3. read more By Gabrielle Masson In the wake of the COVID-19 pandemic, 35 industry giants from both the oncology and biopharma worlds including Johnson & Johnson, Novartis and more are calling for permanent global changes in cancer treatment and delivery. read more By Nick Paul Taylor Question: What links Ed Kaye, John Maraganore, David Meeker and a handful of other storied biopharma execs? Answer: They have all financially backed and agreed to advise a Dutch startup that just raised a seed round to support the development of a rare disease drug. read more By Fraiser Kansteiner Eighty-six percent of GSK Unite members voted in favor of the strike, giving GSK just 48 hours to make a “much-improved offer” lest they act, the union said. Unite is angling for a pay increase more closely aligned to the local rate of inflation, which hit a 30-year high in the U.K. of 7% back in March. read more By Gareth Macdonald Thread has acquired technology firm Cureclick, continuing a string of recent acquisitions designed to expand its decentralized trials business. read more By Angus Liu In the run-up to the Biden administration’s final Medicare coverage decision for Aduhelm, Biogen hired an unusual lobbyist to jockey for patient access. read more By Andrea Park Like a young joey carried safely in a marsupial's pouch, so too will devicemaker Phenox be tucked into its new parent company, the aptly named Wallaby Medical. read more By Paige Minemyer Louisiana Attorney General Jeff Landry has sued UnitedHealth Group, claiming that the healthcare and insurance giant has inflated drug charges in the state's Medicaid program by billions. read more By Darius Tahir, Kaiser Health News Although the gadgets are a technical achievement, some cardiologists say the information the devices produce isn’t always useful. read more Resources Sponsored By: H1 More than 570 clinical trials in Ukraine have been disrupted. Unanticipated disruptions to medical testing and clinical trials impede progress toward new breakthroughs and new therapies that millions of patients around the world hang their hope on. What role do rescue sites play? Sponsored by: Nethealth Net Health, experts in wound care and dermatology clinical trials, have a new eBook: 5 Rules to Enhance Clinical Trials in 2022, find out how to recruit the right participants, connect patients and researchers with technology, manage costs and more. Sponsored by: United Cargo The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now. Presented By: Springer Nature The journey of drug development in 2021 delivered to your inbox: top 10 AdisInsight drug profiles viewed, new drug profiles released, overview of drug launches, key deals, research trends in 2021 and much more (free of charge). Sponsored by: Blue Matter, strategic consultants in the life sciences What’s in store for the oncology market in 2022 and beyond? This paper looks at 5 trends driving the market. Sponsored by: Thermo Fisher Scientific Learn how to position quality as a central component within your raw material sourcing strategies for the chemicals used throughout your workflows. Download the free whitepaper from Thermo Fisher Scientific. Sponsored by: Oracle Health Sciences Learn about ways to break down regulatory roadblocks and get closer to 100% clarity on regulatory positions to advance decentralized clinical trials in research. Cancer Progress 2022: Hear from Leading Oncology Innovators May 10-12, 2022 | Virtual Accelerating Immuno-Oncology and Oncology Drug Development Using Humanized Mice Live & Recorded on: Thursday, April 21, 2022 | 12pm ET / 9am PT Fierce Trial Master File Summit May 2-4, 2022 | New Orleans, LA & Streaming Live Fierce Leaders in Life Sciences Forum May 24, 2022 | Free Virtual Event Fierce Digital Pharma Engage June 14-15, 2022 | Huntington Beach, CA Fierce Digital Pharma Innovation Week June 21-23, 2022 | Virtual Event Fierce Biotech Next Gen June 29-30, 2022 | Free Virtual Event Fierce Pharma PR & Communications Summit East July 19-20, 2022 | Jersey City, NJ Fierce New Product Planning Summit September 20-22, 2022 | Boston, MA Fierce Digital Pharma East October 18-20, 2022 | Philadelphia, PA & October 25-28, 2022 | Virtual Event Fierce Biotech Cell & Gene Therapy Forum October 19, 2022 | Virtual Event Fierce Pharma Meeting Professionals Summit November 2-3, 2022 | Atlantic City, NJ Fierce European Trial Master File Summit November 14-16, 2022 | London, UK Fierce Launch Readiness for Medical Affairs & Communications Teams Summit November 30-December 1, 2022 | Virtual Event Fierce JPM Week 2023 January 2023 | San Francisco, CA & Virtual | 
